Squarepoint Ops LLC Actinium Pharmaceuticals, Inc. Transaction History
Squarepoint Ops LLC
- $99.2 Billion
- Q4 2024
A detailed history of Squarepoint Ops LLC transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 183,262 shares of ATNM stock, worth $225,412. This represents 0.0% of its overall portfolio holdings.
Number of Shares
183,262
Previous 146,103
25.43%
Holding current value
$225,412
Previous $274,000
16.06%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ATNM
# of Institutions
70Shares Held
7.94MCall Options Held
59.6KPut Options Held
4.8K-
Black Rock Inc. New York, NY1.88MShares$2.31 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.62MShares$1.99 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA688KShares$846,0590.0% of portfolio
-
State Street Corp Boston, MA621KShares$763,9220.0% of portfolio
-
Acadian Asset Management LLC Boston, MA499KShares$614,0890.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $31M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...